CHEK2 and glioblastoma: The scRNA-seq data of GBM patients28 showed enrichment of antigen presentation pathway in low CHEK2 expressing tumor cells as compared to the high CHEK2 expressing tumor cells (p = 3.2e−08; Fig. 4a).